Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Replimune Group Inc (REPL)

Replimune Group Inc (REPL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Replimune Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Tue Nov 12, 7:00AM CST

REPL : 11.40 (-2.48%)
Replimune Presents Late-Breaking Abstract Featuring Data from IGNYTE Clinical Trial of RP1 Combined with Nivolumab in Anti-PD1 Failed Melanoma at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2024) GlobeNewswire - Sat Nov 9, 12:00PM CST

REPL : 11.40 (-2.48%)
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Fri Nov 8, 3:01PM CST

REPL : 11.40 (-2.48%)
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) GlobeNewswire - Wed Oct 30, 8:15AM CDT

REPL : 11.40 (-2.48%)
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Oct 9, 3:01PM CDT

REPL : 11.40 (-2.48%)
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks Motley Fool - Wed Aug 24, 2022

This billionaire-guided hedge fund went bargain-shopping in the second quarter.

AFMD : 3.65 (-2.67%)
CERS : 1.8000 (-3.23%)
REPL : 11.40 (-2.48%)
Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update Globe Newswire - Thu Aug 4, 2022

Target enrollment of 180 patients reached in the CERPASS randomized controlled registration-directed clinical trial evaluating RP1 in cutaneous squamous...

REPL : 11.40 (-2.48%)
Replimune to Present at Two Upcoming Investor Conferences Globe Newswire - Mon Aug 1, 2022

WOBURN, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...

REPL : 11.40 (-2.48%)
Replimune Announces the Departure of Jason Rhodes from its Board of Directors Globe Newswire - Fri Jun 3, 2022

WOBURN, Mass., June 03, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development...

REPL : 11.40 (-2.48%)
Replimune To Present at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting Globe Newswire - Thu May 26, 2022

Presentations include recently updated results from the skin cancer cohort of IGNYTE, an ongoing Phase 1/2 study of RP1 combined with Opdivo® (nivolumab),...

REPL : 11.40 (-2.48%)

Barchart Exclusives

Geo Group vs. CoreCivic: Which Stock is a Better Buy? Barchart - 3 minutes ago
Shares of both GEO Group and CoreCivic are surging as Donald Trump reclaims the White House. But which of these two stocks is a better investment candidate now? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot